Skip to main content
SpringerLink
Log in

The Regulation of Dietary Supplements in the Republic of Armenia

  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

Sixty-one dietary supplements are currently registered in Armenia and interest in these products has been growing. In 1996, the Armenian Drug and Medical Technology Agency of the Ministry of Health adopted the “Resolution of Licensing of Dietary Supplement Products.” This resolution is based upon the Drug Law of Armenia of 1998, which excludes from registration in Armenia any drugs that are detrimental to public health due to the uncontrolled sale of such products and the lack of information about them. The Drug and Medical Technology Agency created a product database with information about registered dietary supplements manufacturers, ingredients, and claims.

The resolution and the database demonstrate the Drug and Medical Technology Agency’s dietary supplement expertise and evaluation criteria. The parameters for rejected dietary supplement applications are included and the requirements for dietary supplement labels are described. To prevent adulterated or counterfeit dietary supplements from being marketed in Armenia, special controls were introduced for some categories of dietary supplements (sedatives, hypoglycemic supplements, tonics, and arthritis supplements).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. US Food and Drug Administration. Center for Food Safety and Applied Nutrition. Overview of Dietary Supplements. January 3. 2001. http://www.cfsan.fda.gov/~dms/ds-oview.html.

    Google Scholar 

  2. Bouldin AS. Smith MC. Banahan BF, McCaffrey DJ. Croom EM. Herbal supplement information and the consumer. Drug Inf J. 2000;34:1339–1353.

    Article  Google Scholar 

  3. Amroyan E, Zakaryan A. Consumer information about herbal dietary supplements. Drugs Med. 2001; 2:33–41.

    Google Scholar 

  4. US Food and Drug Administration, Center for Food Safety and Applied Nutrition. Illness and Injuries Associated with the Use of Selected Dietary Supplements. http://vm.cfsan.fda.gov/~dms/ds-ill.html.

  5. US Food and Drug Administration. Talk Paper. FDA Warns about GBL-related Products. May 11. 1999. http://fda.gov/bbs/topics/ANSWERS/ANS0O953.2html.

    Google Scholar 

  6. Budazinski JW, Foster BC, Vandenhoek S, Hanna J, Aranson JT. An in vitro evaluation of human cytochrome p-450 3a4 inhibition by selected commercial herbal extracts and tinctures. Phytomed. 2000; 7 (4): 273–282.

    Article  Google Scholar 

  7. Taylor JR, Wilt VM. Probable antagonism of warfarin with green tea. Ann Pharmacother. 1999;33:426.

    Article  CAS  Google Scholar 

  8. US Congress Senate Bill S.784. Dietary Supplement Health and Education Act of 1994.

    Google Scholar 

  9. Royal Decree on Herbal Food Products (Warenwetb-esluit Kruiden-preparaten) Staatsblad 56. The Netherlands. January 31, 2001.

    Google Scholar 

  10. Bryan Q, Coleman L, Meisberger S, Copmann T. Issues in the regulation of dietary supplements. Drug Inf J. 2001;35:529–538.

    Article  Google Scholar 

  11. Arbeitskreis Lebensmittelchemischer Sachverstan-diger der Lander und des BgW. Bundesgesundheit-sbl-Gesundheitsforsch-Gesundheitsschutz. 1999;42: 360–361.

    Article  Google Scholar 

  12. Drug Law of the Republic of Armenia. Yerevan, Armenia. October 8, 1998.

    Google Scholar 

  13. Amirdowlat Amasyaci. Needless for Ignoramus. Moscow, Union of Soviet Socialist Republics; Nauka: 1990.

    Google Scholar 

  14. World Health Organisation and Drug and Medical Technology Agency Republic of Armenia Workshop Report. The Progress in Realization of National Drug Policy in Armenia Since 1994 to 2000. Yerevan, Armenia. 2001.

    Google Scholar 

  15. De Smet PAGM. Overview of herbal quality control. Drug Inf J. 1999;33:717–724.

    Article  Google Scholar 

  16. Dzulkifli AR. Poison Control: Traditional Medicine and the Use of Steroids as Adulterants. Malaysia: The National Poison Centre at University Sains Malaysia. http://pm.usm.my/steroids/index.html.

  17. US Food and Drug Administration. Talk Paper. FDA Warns Against Consuming Triax Metabolic Accelerator. November 11, 1999. http://fda.gov/bbs/topics/ANSWERS/ANS00984.html.

    Google Scholar 

  18. Russian Federation Ministry of Health Guidance. Assessment of Certification of BADS. Moscow, Russia; 1997.

    Google Scholar 

  19. World Health Organisation/Essential Drugs and Medicines/Traditional Medicine. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Annex V. Guidelines for Levels and Kinds of Evidence to Supports Claims for Therapeutic Goods. Geneva, Switzerland: World Health Organisation. 2000.

    Google Scholar 

  20. US Food and Drug Administration. Talk Paper. FDA Finalizes Rules for Claims on Dietary Supplements. Rockville, MD: US Food and Drug Administration; January 5, 2000.

    Google Scholar 

  21. Food Labeling; Notification Procedures for Statements on Dietary Supplements. Federal Register. 1997; 62(184): 49883–49886.

    Google Scholar 

  22. Kurtzweil P. An FDA guide to dietary supplements. US FDA Consumer. October 1998, revised January 1999. http://vm.cfsan.fda.gov/’dms/fdsupp.html.

    Google Scholar 

  23. Gabrielyan E, Amroyan E, Zakaryan A. Adverse effects of biologically active dietary supplements. Urartu (newspaper). 2001; 10.

    Google Scholar 

  24. Gabrielyan E, Amroyan E, Zakaryan A. Consumer information about herbal dietary supplements. Golos Armenii (newspaper). March 1, 2001.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Drug and Medical Technology Agency of Armenia, Yerevan, Armenia

    Emil Gabrielyan MD, DSc (Director)

  2. The Pharmacological Committee, Drug and Medical Technology Agency of Armenia, Yerevan, Armenia

    Elmira Amroyan MD, DSc (Professor, Head)

  3. Guelbenkian Research Laboratory, Yerevan, Armenia

    Alexander Panosyan PhD, DSc (Professor, Head)

  4. Drug and Medical Technology Agency of Armenia, Yerevan, Armenia

    Annet Zakaryan PhD (Senior Expert)

Authors
  1. Emil Gabrielyan MD, DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elmira Amroyan MD, DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Panosyan PhD, DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Annet Zakaryan PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elmira Amroyan MD, DSc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gabrielyan, E., Amroyan, E., Panosyan, A. et al. The Regulation of Dietary Supplements in the Republic of Armenia. Ther Innov Regul Sci 36, 889–897 (2002). https://doi.org/10.1177/009286150203600418

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286150203600418

Key Words

Search

Navigation